Literature DB >> 15878738

Altered renal elimination of organic anions in rats with chronic renal failure.

Adriana Mónica Torres1, Myriam Mac Laughlin, Angélica Muller, Anabel Brandoni, Naohiko Anzai, Hitoshi Endou.   

Abstract

The progress of chronic renal failure (CRF) is characterized by the development of glomerular and tubular lesions. However, little is known about the expression of organic anions renal transporters. The objective of this work was to study, in rats with experimental CRF (5/6 nephrectomy), the expression of the organic anion transporter 1 (OAT1) and organic anion transporter 3 (OAT3) and their contribution to the pharmacokinetics and renal excretion of p-aminohippurate (PAH). Two groups of animals were used: Sham and CRF. Six months after surgery, systolic blood pressure and plasma creatinine concentrations were significantly higher in CRF groups. CRF rats showed a diminution in: the filtered, secreted and excreted load of PAH; the systemic clearance of PAH; the renal OAT1 expression; and the renal Na-K-ATPase activity. No remarkable modifications were observed in the OAT3 expression from CRF kidneys. The diminution in the systemic depuration and renal excretion of PAH may be explained by the decrease in its filtered and secreted load. The lower OAT1 expression in remnant renal mass of CRF rats or/and the lower activity of Na-K-ATPase might justify, at least in part, the diminished secreted load of this organic anion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15878738     DOI: 10.1016/j.bbadis.2005.03.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Renal elimination of organic anions in cholestasis.

Authors:  Adriana Monica Torres
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 3.  Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease.

Authors:  Li Wang; Douglas H Sweet
Journal:  AAPS J       Date:  2012-10-09       Impact factor: 4.009

4.  EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

Authors:  Na Liu; Li Wang; Tao Yang; Chongxiang Xiong; Liuqing Xu; Yingfeng Shi; Wenfang Bao; Y Eugene Chin; Shi-Bin Cheng; Haidong Yan; Andong Qiu; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

5.  Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.

Authors:  Kevin T Bush; Prabhleen Singh; Sanjay K Nigam
Journal:  JCI Insight       Date:  2020-04-09

6.  Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury.

Authors:  Adriana M Torres; Ankur V Dnyanmote; Kevin T Bush; Wei Wu; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 7.  Loops and layers of post-translational modifications of drug transporters.

Authors:  Da Xu; Guofeng You
Journal:  Adv Drug Deliv Rev       Date:  2016-05-09       Impact factor: 15.470

Review 8.  Posttranslational Regulation of Organic Anion Transporters by Ubiquitination: Known and Novel.

Authors:  Da Xu; Haoxun Wang; Guofeng You
Journal:  Med Res Rev       Date:  2016-06-12       Impact factor: 12.944

9.  Proteasome Inhibitors Bortezomib and Carfilzomib Stimulate the Transport Activity of Human Organic Anion Transporter 1.

Authors:  Yunzhou Fan; Guofeng You
Journal:  Mol Pharmacol       Date:  2020-03-31       Impact factor: 4.436

10.  Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.

Authors:  Yan Chen; Leila R Zelnick; Ke Wang; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; Tariq Shafi; Stephen L Seliger; Michael G Shlipak; Mahboob Rahman; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2020-03-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.